These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 39098057)
1. Longitudinal epidemiology of multiple sclerosis over 60 years in Newcastle, Australia: 1961 to 2021. Simpson-Yap S; Maltby VE; Hall S; Ward S; Lea R; Boggild M; Kalincik T; Shaw C; Taylor B; van der Walt A; Lechner-Scott J Mult Scler Relat Disord; 2024 Oct; 90():105786. PubMed ID: 39098057 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022. Simpson-Yap S; Maddox D; Reece J; Lechner-Scott J; Shaw C; Taylor B; Kalincik T; van der Walt A; Boggild M Mult Scler Relat Disord; 2023 Sep; 77():104845. PubMed ID: 37442078 [TBL] [Abstract][Full Text] [Related]
3. Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study. Ribbons K; Lea R; Tiedeman C; Mackenzie L; Lechner-Scott J Mult Scler; 2017 Jul; 23(8):1063-1071. PubMed ID: 27682228 [TBL] [Abstract][Full Text] [Related]
4. Increasing incidence and prevalence of multiple sclerosis in the Greater Hobart cohort of Tasmania, Australia. Simpson-Yap S; Atvars R; Blizzard L; van der Mei I; Taylor BV J Neurol Neurosurg Psychiatry; 2022 May; ():. PubMed ID: 35577508 [TBL] [Abstract][Full Text] [Related]
5. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. Barnett MH; Williams DB; Day S; Macaskill P; McLeod JG J Neurol Sci; 2003 Sep; 213(1-2):1-6. PubMed ID: 12873746 [TBL] [Abstract][Full Text] [Related]
6. Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009. Simpson S; Pittas F; van der Mei I; Blizzard L; Ponsonby AL; Taylor B J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):180-7. PubMed ID: 21097824 [TBL] [Abstract][Full Text] [Related]
7. Significantly increasing multiple sclerosis prevalence in Australia from 2010 to 2021. Campbell JA; Simpson-Yap S; Taylor BV; van der Mei I; Laslett L; Henson G; Zhao T; Palmer AJ Mult Scler; 2024 Aug; 30(9):1113-1127. PubMed ID: 39104180 [TBL] [Abstract][Full Text] [Related]
8. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study. O'Connell K; Tubridy N; Hutchinson M; McGuigan C Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707 [TBL] [Abstract][Full Text] [Related]
9. The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation. Carod-Artal FJ Mult Scler Relat Disord; 2021 Jan; 47():102657. PubMed ID: 33302230 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results. McLeod JG; Hammond SR; Hallpike JF Med J Aust; 1994 Feb; 160(3):117-22. PubMed ID: 8295576 [TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of paediatric-onset multiple sclerosis in two Canadian provinces: a population-based study representing over half of Canada's population. Yusuf FLA; Asaf A; Marrie RA; Li P; McKay K; Zhao Y; Zhu F; Maxwell C; Tremlett H J Neurol Neurosurg Psychiatry; 2024 Feb; 95(3):229-234. PubMed ID: 37734925 [TBL] [Abstract][Full Text] [Related]
12. Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data. Campbell JA; Simpson S; Ahmad H; Taylor BV; van der Mei I; Palmer AJ Mult Scler; 2020 Oct; 26(11):1315-1328. PubMed ID: 31347952 [TBL] [Abstract][Full Text] [Related]
13. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. Moisan F; Kab S; Mohamed F; Canonico M; Le Guern M; Quintin C; Carcaillon L; Nicolau J; Duport N; Singh-Manoux A; Boussac-Zarebska M; Elbaz A J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):952-7. PubMed ID: 26701996 [TBL] [Abstract][Full Text] [Related]
14. Increasing prevalence of multiple sclerosis in Västerbotten County of Sweden. Svenningsson A; Salzer J; Vågberg M; Sundström P; Svenningsson A Acta Neurol Scand; 2015 Dec; 132(6):389-94. PubMed ID: 25857351 [TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register. Robertson N; Deans J; Fraser M; Compston DA J Epidemiol Community Health; 1996 Jun; 50(3):274-9. PubMed ID: 8935458 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain). Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359 [TBL] [Abstract][Full Text] [Related]
18. Age and sex adjusted prevalence and annual incidence of multiple sclerosis in East-Azerbaijan, Iran. Talebi M; Sadigh-Eteghad S; Sahraian MA; Fahidi A Mult Scler Relat Disord; 2021 May; 50():102839. PubMed ID: 33592381 [TBL] [Abstract][Full Text] [Related]
19. Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Hader WJ; Yee IM Neurology; 2007 Sep; 69(12):1224-9. PubMed ID: 17875910 [TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis epidemiology in Finland: Regional differences and high incidence. Pirttisalo AL; Soilu-Hänninen M; Sipilä JOT Acta Neurol Scand; 2019 Apr; 139(4):353-359. PubMed ID: 30480315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]